Old Web
English
Sign In
Acemap
>
authorDetail
>
K Micetich
K Micetich
Pathology
Cetuximab
Bevacizumab
Pancreatic cancer
Phases of clinical research
4
Papers
58
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Final analysis of a randomized phase II study of bevacizumab (B) and gemcitabine (G) plus cetuximab (C) or erlotinib (E) in patients (pts) with advanced pancreatic cancer (PC)
2008
Journal of Clinical Oncology
Hedy L. Kindler
Tara Gangadhar
Theodore Karrison
Howard S. Hochster
M. J. Moore
K Micetich
W Sun
Daniel V.T. Catenacci
Walter M. Stadler
E. E. Vokes
Show All
Source
Cite
Save
Citations (29)
A randomized phase II study of bevacizumab (B) and gemcitabine (G) plus cetuximab (C) or erlotinib (E) in patients (pts) with advanced pancreatic cancer (PC): A preliminary analysis
2006
Journal of Clinical Oncology
Hedy L. Kindler
K.A. Bylow
Howard S. Hochster
Gregory Friberg
K Micetich
Gershon Y. Locker
Mark Kozloff
M. J. Moore
W. Sun
E. E. Vokes
Show All
Source
Cite
Save
Citations (16)
Mechanism of resistance to cis-dichlorodiammine-platinum(ii) (ddp) in a line of l1210 cells. Abstr.
1981
K Micetich
Stephen Michaels
G Jude
Kurt W. Kohn
Leonard A. Zwelling
Show All
Source
Cite
Save
Citations (0)
1